Professional development and knowledge exchange in the pharmaceutical industry are more critical now than ever before, as the COVID-19 pandemic continues to have an unforeseeable global impact. It is essential to keep knowledge thriving to help drive the pharmaceutical industry forward and enhance patient health and safety worldwide.
We are pleased to announce that we are transforming Europe’s most comprehensive event on the latest innovations in pharmaceutical manufacturing to be fully digital: the 2020 ISPE Europe Annual Virtual Conference, taking place on 16–17 September 2020. As a bonus, delegates will receive access to the recording of all conference sessions for one year.
Nowhere else will you get real-time engagement with 13 regulatory agencies, including AEMPS, AIFA, ANSM, EMA, FDA, FSI SID&GP, MHRA, WHO, and more as they provide insights on how COVID-19 is impacting the challenges of drug shortages, distant assessments, and GMP reliance.
In addition to new content focused on industry response and issues associated with the COVID-19 pandemic, delegates will still benefit from robust, content-rich, interactive sessions covering critical topics like digitisation, the FDA’s continuous manufacturing draft guidance, aseptic processing, Annex 1, small molecules, and more.
It's our priority to make this the best and most informative ISPE Europe Annual Virtual Conference to date, and we remain excited to host you in September.
Featured Regulatory Panel
Regulators' View on COVID-19
Examine how digitalisation in light of COVID-19 has created opportunities and limitations for preparedness, reactivity, crisis management, quality execution, and more. Panel includes: